Atlas Trials

Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients

Clinical trial NCT02327689 · UNKNOWN

Trial details

NCT number
NCT02327689
Sponsor
Asian-Pacific Alliance of Liver Disease, Beijing
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B, ChronicFibrosis
Start date
2015-01-01
Primary completion
2015-07-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.